[Experiences with N-Lost phosphamide esters].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004952:Esters; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D010954:Plasmacytoma / Q000188:drug therapy; D013964:Thyroid Neoplasms / Q000188:drug therapy
D004952:Esters; D009588:Nitrogen Mustard Compounds
Erfahrungen mit neuartigen N-Lost-Phosphamidestern.